Can-Fite Biopharma Ltd., of Petach Tikva, Israel, said it entered a definitive agreement with certain institutional investors to receive gross proceeds of $6 million. The firm will issue 1.5 million American depositary shares (ADS) at $4 per ADS in a registered direct offering.